Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Shigenobu Fujii"'
Autor:
Tagahiko Morinaga, Kimio Yasuhira, Masataka Watanabe, Yasuhiro Shindo, Nobuyoshi Sumi, Shigenori Furukawa, Shigenobu Fujii, Mikito Kikumori
Publikováno v:
The Journal of Toxicological Sciences. 21:187-206
A study of the effect of prulifloxacin, a new antibacterial agent, during the period of organogenesis was conducted in Sprague-Dawley rats. Female rats were given prulifloxacin orally at dose levels of 0 (control), 30, 300, and 3000 mg/kg from day 7
Autor:
Tagahiko Morinaga, Shigenobu Fujii, Kimio Yasuhira, Mikito Kikumori, Yasuhiro Shindo, Masataka Watanabe, Shigenori Furukawa, Nobuyoshi Sumi
Publikováno v:
The Journal of Toxicological Sciences. 21:207-217
A study of the effect of prulifloxacin, a new antibacterial agent, during the period of organogenesis was conducted in New Zealand White rabbits. Female rabbits were given prulifloxacin orally at dose levels of 0 (control), 10, 30 and 100 mg/kg from
Autor:
Shigenori Furukawa, Tagahiko Morinaga, Kimio Yasuhira, Shigenobu Fujii, Masataka Watanabe, Nobuyoshi Sumi, Mikito Kikumori
Publikováno v:
The Journal of Toxicological Sciences. 20:259-275
A study of fertility and early embryonic development to implantation of montirelin hydrate (NS-3), a new drug for the treatment of disturbance of consciousness, was conducted in Sprague-Dawley rats. Male rats were given the drug intravenously from 63
Autor:
Masataka Watanabe, Nobuyoshi Sumi, Yasuhiro Shindo, Shigenobu Fujii, Kimio Yasuhira, Tagahiko Morinaga, Mikito Kikumori, Shigenori Furukawa
Publikováno v:
The Journal of toxicological sciences. 21
A peri- and postnatal study of prulifloxacin, a new antibacterial agent, was conducted in Sprague-Dawley rats. Female rats were given prulifloxacin orally at dose levels of 0 (control), 30, 100 and 300 mg/kg from day 17 of pregnancy to day 21 after d